Drug General Information
Drug ID
D0Q7QY
Former ID
DCL001000
Drug Name
SSR-125047
Drug Type
Small molecular drug
Indication Schizophrenia [ICD9: 295; ICD10:F20] Phase 1 [536463]
Company
Sanofi-Aventis
Structure
Download
2D MOL

3D MOL

Formula
C16H14F3NO3S
Canonical SMILES
CN(CC(=O)O)C(=S)C1=CC=CC2=C1C=CC(=C2C(F)(F)F)OC
InChI
1S/C16H14F3NO3S/c1-20(8-13(21)22)15(24)11-5-3-4-10-9(11)6-7-12(23-2)14(10)16(17,18)19/h3-7H,8H2,1-2H3,(H,21,22)
InChIKey
LUBHDINQXIHVLS-UHFFFAOYSA-N
PubChem Compound ID
PubChem Substance ID
ChEBI ID
ChEBI:48549
SuperDrug ATC ID
A10XA01
SuperDrug CAS ID
cas=082964043
Target and Pathway
Target(s) Sigma(1)-type opioid receptor Target Info Binder [536463]
WikiPathways miR-targeted genes in squamous cell - TarBase
miR-targeted genes in lymphocytes - TarBase
References
Ref 536463The pipeline and future of drug development in schizophrenia. Mol Psychiatry. 2007 Oct;12(10):904-22. Epub 2007 Jul 31.
Ref 536463The pipeline and future of drug development in schizophrenia. Mol Psychiatry. 2007 Oct;12(10):904-22. Epub 2007 Jul 31.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.